Evolution of the Average Target: Lonza Group AG

Evolution of the Target Price: Lonza Group AG

Changes in Analyst Recommendations: Lonza Group AG

9196b4ec1eac48825352245c01ab27f._ixfCXbUlZ6LezKPpQyO6ElwrwcgsZxnj4p2e30wQss.pk83OjWupOvNGmL541XNmw8l9jFPgqhRyvg7SjwGFJuGGwBWD-ekzvkwRQ~61b9f6fe4c336ea83532ba035fe746de
23/06 Swiss stocks - Factors to watch on June 23 RE
16/06 Swiss stocks - Factors to watch on June 16 RE
10/06 AlphaValue/Baader Europe Cuts EPS Forecasts for Lonza Group on Division Sale MT
09/06 Lonza Group: Incorporating Capsules & Health Ingredients divestment Alphavalue
04/06 Intron Health Downgrades Lonza Group to Sell, Cuts PT MT
11/05 Morningstar Upgrades Lonza Group to Buy MT
08/05 Lonza Group: Q1 commentary in line; 2026 guidance reaffirmed Alphavalue
27/04 AlphaValue/Baader Europe Upgrades Lonza Group to Buy, Lifts PT MT
27/04 RBC Expects 'Uneventful' Lonza Q1 Update; Outperform Maintained MT
15/04 Berenberg: Lonza Group's Recent Subdued Valuation 'Good Entry Point'; Estimates Adjusted MT
14/04 Swiss stocks - Factors to watch on April 14 RE
28/01 Lonza Group: Ended 2025 on a high note Alphavalue
05/01 Analyst Calls of the Day: Lower Targets for Arkema and Legrand, Pandora Punished Zonebourse
25/11 Morgan Stanley Upgrades Lonza Group to Overweight, Lifts PT MT
23/25/23 Lonza Group: Strong Q3 performance commentary aligns with full-year goals Alphavalue
28/25/28 AlphaValue/Baader Europe Upgrades Lonza Group on FY25 Guidance Lift, Robust Business Momentum MT
25/25/25 Lonza Group: Recognising the strength of the CDMO business Alphavalue
24/25/24 BofA Keeps Lonza Group at Buy After 'Very Strong' H1 MT
23/25/23 Lonza Group: H1 beat and full-year guidance upgrade impress the markets Alphavalue
09/25/09 Lonza Group: Stronger profitability due to positive mid-term customer demand Alphavalue
12/25/12 AlphaValue/Baader Europe Remains Upbeat on Lonza, Reassesses Financial Estimates MT
12/25/12 Lonza Group: Strong Confidence for 2025 Alphavalue
01/25/01 Swiss Market Index Recovers; Galderma Group Shares Rise MT
04/25/04 RBC Lifts Lonza Group's Price Target Amid Higher Earnings Expectations MT
26/25/26 Lonza Group: The Vacaville effect becomes more impactful Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+14.2%
+7.17%
+10.48%
+38.11%
+46.5%
+9.89%
-16.13%
+3%
+7.81%
+12.74%
Average +13.38%
Weighted average by Cap. +15.98%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
586.00CHF
Average target price
669.22CHF
Spread / Average Target
+14.20%
High Price Target
815.00CHF
Spread / Highest target
+39.08%
Low Price Target
550.00CHF
Spread / Lowest Target
-6.14%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

alphavalue Anas Patel
Intron Health
Morningstar
AlphaValue/Baader Europe
Morgan Stanley
Stifel Nicolaus
Berenberg Bank
Deutsche Bank Securities
Jefferies & Co.
Equita
Research Capital
Societe Generale
Octagon Capital
RBC Capital Markets
Bernstein
International Strategy & Investment Group
HSBC
Credit Suisse
Mirae Asset Group
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
586.00CHF
Average target price
669.22CHF
Spread / Average Target
+14.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LONN Stock
  4. Consensus Lonza Group AG